Optimal administration of fosaprepitant in patients with colon cancer
Latest Information Update: 27 Sep 2013
At a glance
- Drugs Fosaprepitant (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions
- 25 Sep 2013 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan.
- 09 Mar 2013 New trial record